Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $47.4 million.

  • Camp4 Therapeutics' Cash from Financing Activities rose 1237564.77% to $47.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 million, marking a year-over-year increase of 832740.94%. This contributed to the annual value of $71.7 million for FY2024, which is 2370797.34% up from last year.
  • Camp4 Therapeutics' Cash from Financing Activities amounted to $47.4 million in Q3 2025, which was up 1237564.77% from $72000.0 recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Cash from Financing Activities ranged from a high of $73.1 million in Q4 2024 and a low of -$812000.0 during Q2 2024
  • For the 3-year period, Camp4 Therapeutics' Cash from Financing Activities averaged around $14.9 million, with its median value being -$107000.0 (2023).
  • As far as peak fluctuations go, Camp4 Therapeutics' Cash from Financing Activities surged by 11607142.86% in 2024, and later skyrocketed by 2524.75% in 2025.
  • Over the past 3 years, Camp4 Therapeutics' Cash from Financing Activities (Quarter) stood at -$63000.0 in 2023, then surged by 116071.43% to $73.1 million in 2024, then crashed by 35.15% to $47.4 million in 2025.
  • Its Cash from Financing Activities stands at $47.4 million for Q3 2025, versus $72000.0 for Q2 2025 and -$151000.0 for Q1 2025.